1-(2-thienylmethyl)-4-piperidinamine dihydrochloride, 95.0%, 10g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one, 97%, 1g

(1R,2S)-1-Amino-1-phenylpropan-2-ol hydrochloride, 97.0%, 250mg

N-(1,3,4-THIADIAZOL-2-YL)NICOTINAMIDE, 98%, 250mg

6-Bromo-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one, 95%, 250mg

4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone, 97.0%, 1g

3-Hydroxy-2-(2-hydroxyphenyl)-4H-1-benzopyran-4-one, 98%, 1g

4-Methyl-1H-pyrrolo[3,2-c]pyridine, 95.0%, 250mg

2,2-Difluoro-2-(quinolin-6-yl)acetic acid, 97%, 100mg

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,2-diaminoethane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g

1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid xhydrochloride, 98.0%, 25g

2,4-Dimethylphenylacetonitrile, 99.0%, 100mg

10-Methyl-9-phenylacridinium Perchlorate>98.0%(HPLC)(N)1g